Discover

TIVC
Tivic Health Systems Inc
1.40
2 x 0.99
2 x 1.60
bid
ask
+
1.40
0.00%
2 @ 04:00 PM
1.43 +0.03 (2.11%)
Ytd-3.45%
1y-63.16%
1.23
day range
1.40
0.20
52 week range
2.24
Open1.30Prev CloseLow1.23High1.40Mkt Cap1.85M
Vol263.29KAvg Vol5.67MEPS5.37P/E0.04Forward P/E-0.01
Beta2.41Short Ratio0.12Inst. Own3.64%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg0.27200-d Avg0.521yr Est210.00
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-142024-090-0.23N/AN/A
2024-08-142024-060-0.32N/AN/A
2024-05-152024-030-1.01N/AN/A
2024-03-252023-120N/AN/AN/A
2023-11-142023-09-7-1.485.5278.86%
2023-08-142023-06-8-7112.50%
Upgrade / Downgrade
DateFirmActionFromTo
Profile
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Insider Holder
DateNameRelationQuantityDescription
2024-03-11BAMBACH KIMBERLY ANNChief Financial Officer7.50KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29UBS Group AG94.30K21.16K1.14%
2024-09-29Vanguard Group Inc47.98K10.77K0.58%
2024-09-29Geode Capital Management, LLC36.46K8.18K0.44%
2024-09-29Two Sigma Securities, LLC28.52K6.40K0.35%
2024-09-29Virtu Financial LLC20.94K4.70K0.25%
2024-09-29Tower Research Capital LLC (TRC)18.36K4.12K0.22%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Extended Market Index Fund47.98K10.77K0.58%
2024-10-30Fidelity Extended Market Index Fund30.67K6.88K0.37%
2024-10-30Fidelity Series Total Market Index Fund1.72K385.000.02%
Split
SplitDate
1 : 172025-03-07
1 : 1002023-08-23